Background {#Sec1}
==========

Obesity and its consequences remain at epidemic levels, particularly for medically vulnerable individuals. The associated comorbidities of obesity (i.e. diabetes, hypertension, chronic kidney disease) are particularly rampant among the medically vulnerable, who are characterized by socioeconomic disadvantage, racial/ethnic minority status, and/or residence in rural locations \[[@CR1]--[@CR7]\].

Moreover, obesity is recalcitrant to treatment \[[@CR8], [@CR9]\], particularly for medically vulnerable populations \[[@CR10], [@CR11]\]. Most trials, including primary care-based interventions, report smaller and less clinically-meaningful weight loss outcomes among such groups \[[@CR10]--[@CR12]\]. We suspect disparities in weight loss outcomes may result, in part, from limited interest in and/or motivation for weight loss within medically vulnerable groups.

In fact, up to one-half of individuals with obesity are not ready for, or interested in, weight loss \[[@CR13]--[@CR15]\], and disinterest is especially common in medically vulnerable populations \[[@CR14]\]. In addition, motivation, a critical predictor of weight loss initiation and success \[[@CR16]--[@CR18]\], is low among participants, even in culturally-targeted interventions \[[@CR19]\]. Both Black \[[@CR20]\] and Latino individuals \[[@CR21]\] have less motivation for weight change, relative to White individuals \[[@CR22]\].

Without efficacious treatment, weight gain will likely occur. Therefore, for patients who are not ready for weight loss, clinical practice guidelines recommend that providers counsel their patients on preventing further weight gain \[[@CR23]\]. Although weight loss reduces cardiometabolic risk \[[@CR24]\], weight gain prevention can halt or slow progression \[[@CR25]--[@CR27]\]. This makes weight gain prevention an important part of comprehensive obesity care \[[@CR3], [@CR25]--[@CR27]\].

However, weight gain prevention interventions are not routinely available in primary care practice. This evidence gap disproportionately affects medically vulnerable patients who have the highest rates of obesity and weight gain, but the least interest in, readiness for, and successes with weight loss. In previous work, we demonstrated successful weight gain prevention over 18 months among Black female primary care patients \[[@CR28]\]. Here, we seek to extend those findings to an entire primary care health system, using a lower intensity intervention that has the potential to improve cost-effectiveness and dissemination potential.

The purpose of the present investigation is to conduct a 24-month pragmatic randomized controlled trial of a comprehensive, digital weight gain prevention intervention delivered in primary care practice among a medically vulnerable patient population.

Methods/Design {#Sec2}
==============

In Balance ("Equilibrio" in Spanish), we will randomize 442 adults who are served at a participating community health center and classified as having overweight or obesity \[Body Mass Index (BMI) of 25--40 kg/m^2^\] to receive: 1) a tailored weight gain prevention intervention; or 2) a standard healthy living usual care program. The primary outcome of-interest is weight gain prevention at 24 months post-randomization, operationally-defined as ≤3% weight gain over baseline weight \[[@CR29], [@CR30]\], among the tailored weight gain prevention intervention arm, as compared to those receiving usual care. Secondary outcome measures include mean difference in weight change; changes in blood pressure and Framingham risk score; and intervention cost-effectiveness, based on trial results at 24-months. Approvals from the Duke Institutional Review Board and Piedmont Health Board of Directors were obtained in 2016. (See Additional file [1](#MOESM1){ref-type="media"} for the SPIRIT figure).

Setting {#Sec3}
-------

Balance will be implemented within Piedmont Health Services, Inc., a private, non-profit Federally Qualified Health Center (FQHC) network in central North Carolina. It operates 10 FQHCs that offer comprehensive family medical and dental care and integrated behavioral health, pharmacy, and support services. A meaningful-use electronic health record (EHR) system is utilized at all sites for behavioral health and medical documentation.

Piedmont Health has approximately 45 full-time equivalent primary care providers who serve more than 38,000 patients annually. The medical patient population is predominantly low-income, diverse (51% Hispanic of any race, 21% Black/African American, 3% Asian), and either uninsured or receiving public insurance (43% uninsured, 29% Medicaid and 10% Medicare). Forty-five percent of patients prefer care in a language other than English, the majority of which is Spanish, and many clinical team members are Spanish-bilingual. Piedmont Health also employs eight registered dietitians, two of whom provide medical nutrition therapy to the general health center population. Around 30% of all adult PHS medical patients have overweight (BMI of 25.0--29.9 kg/m^2^) and 47% have obesity (BMI of 30 kg/m^2^ or greater).

Participants {#Sec4}
------------

Inclusion criteria for the Balance trial are as follows: currently a Piedmont Health patient at a participating health center, aged 21 years or older with a weight measured at an outpatient appointment within the last 14 days; a BMI between 25 and 40 kg/m^2^ (inclusive); and a weight of 380 pounds or less. Eligible participants must also speak English or Spanish as a primary language, have a text-enabled mobile phone and be willing to receive three to 12 weekly study-related text messages.

Due to its pragmatic design, Balance's exclusion criteria are limited. The criteria are designed to ensure participant safety and to allow the collection of follow-up data from the Piedmont Health EHR. As such, patients will be excluded for the following reasons: being a current Piedmont Health employee; pregnancy within 12 months; lactation within two months; having given birth within the last six months; having prior or planned bariatric surgery; participating in another study to lose weight; having a cancer diagnosis and currently receiving treatment; or having a diagnosis of end stage renal disease. Participants will also be excluded if they had a cardiovascular event or hospitalization for a mental health condition within the last 12 months. Patients with a history of coronary artery revascularization within the last 12 months will be allowed to participate in the study with provider approval.

Participant recruitment and screening {#Sec5}
-------------------------------------

To align with the pragmatic design, participants will be recruited through in-person provider referral when seeking care at already-established appointments at Piedmont Health. Providers will speak to potentially-eligible patients about the trial during outpatient appointments, assess their interest and ask them to sign an authorization form to allow research staff to access their medical record. Research staff will then conduct a brief medical chart eligibility screen to verify if patient weight, BMI, and appointment date are within the eligible ranges. If the patient is considered eligible upon chart review, research staff will conduct a phone eligibility screening and continue with informed consent and enrollment procedures.

Randomization {#Sec6}
-------------

We will randomize participants to one of the two arms using permuted block randomization with stratification to balance assignment within the Piedmont Health community health centers. Randomization allocation tables will be created by a statistician using SAS software, version 9.4 (SAS Institute, Cary, NC, USA) with random block sizes ranging from 2 to 6. The tables will be stored within a secure web application at Duke University, REDCap, or Research Electronic Data Capture \[[@CR31]\], in such a way that only the statistician will be able to view them. The random assignment of a participant will be revealed to study staff using REDCap during enrollment. Participants will be screened, enrolled, consented and randomized by research staff on the phone, and subsequently mailed study materials following their enrollment. To minimize contamination and maintain a pragmatic study design, patients who choose to enroll in the trial, but currently live in the same household as another already-enrolled Balance participant (i.e. a friend or family member), will be non-randomly assigned to the same treatment group as the initially-randomized participant. The participants assigned in this non-randomized manner will be excluded from our primary analyses but will still receive the Balance intervention. Trial outcomes will be analyzed blind to allocation status.

Data collection {#Sec7}
---------------

Informed by the PRECIS guidelines (PRagmatic Explanatory Continuum Indicator Summary) \[[@CR32]\], we intentionally designed data collection procedures to maximize pragmatism. All participant baseline and follow-up data will be pulled directly from the Piedmont Health EHR and assessed at 24-months post-randomization (i.e. weights, blood pressure readings, diagnostic codes, visit notes, lab tests, medications, and appointment dates). Our intervention delivery application will be programmed to store data received from self-monitoring prompts and feedback; all inbound and outbound text messages for weight and goal coaching; and daily self-weighing measurements.

Treatment arms {#Sec8}
--------------

Participants will be assigned to one of two treatment arms:

Usual care arm {#Sec9}
--------------

Patients will receive the usual primary care offered at their health center; six months of weekly automated text messages with tips for healthy living; and print materials based on the National Heart Lung and Blood Institute's *Aim for a Healthy Weight* \[[@CR33]\]. Their usual primary care will not be influenced in any other way.

Weight gain prevention intervention arm {#Sec10}
---------------------------------------

Intervention participants will receive: 1) tailored behavior change goals through iOTA (interactive obesity treatment approach); 2) self-monitoring using connected scales and mobile technologies; 3) responsive coaching; and 4) skills training. Each of the four components is described in more detail below:

### Tailored behavior change goals {#Sec11}

Successful weight gain prevention requires the creation of a slight energy deficit (100--200 cal per day), representing a small change on an absolute basis. To achieve this deficit, we will utilize the interactive obesity treatment approach (iOTA). iOTA creates an energy deficit by having participants achieve simple, straightforward, and concrete behavior change goals (e.g., no fast food, no sugary drinks, walk 10,000 steps per day) \[[@CR28], [@CR34]--[@CR36]\]. iOTA is grounded in social cognitive theory \[[@CR37]\], from which self-efficacy will be our primary psychosocial mediator. There is strong and consistent evidence that self-efficacy is positively associated with weight-related behavior change \[[@CR38]--[@CR40]\]. Social cognitive theory indicates that behavior change can be facilitated through self-regulatory processes that we target in the intervention, including self-monitoring \[[@CR41]--[@CR43]\], goal setting \[[@CR38], [@CR44]\], and social support \[[@CR45], [@CR46]\]. iOTA has been tested in several recent primary care-based obesity treatment trials \[[@CR28], [@CR34]--[@CR36], [@CR47]\].

To assign iOTA behavior change goals, Balance participants will be administered a short survey about their current health behaviors (e.g. diet, exercise frequency, sleep, etc.). Our algorithm will rank the participants' behaviors as high need - behaviors that promote weight gain (e.g., consumption of sugary beverages) - or low need - behaviors that create a caloric deficit (e.g., exercising 30 min at least three days per week). If participant answers are categorized as being "high need," they will then be asked to rate their perceived confidence to change these behaviors on a scale of 0 to 100, with 0 indicating "not confident at all" and 100 indicating the "most confident" to change the behavior. (See Fig. [1](#Fig1){ref-type="fig"} for sample survey flow.)Fig. 1Sample iOTA survey flow for "No Sugary Drinks" behavior change goal

Based on the responses, our intervention delivery platform will use an algorithm to create a tailored list of behaviors for each participant. Each participant will then be prescribed the first four tailored behavior change goals to work on concurrently over an eight-week interval: one universal goal that all participants receive and three tailored goals. At the end of each eight-week cycle, four new goals will be assigned based on the prescribed list. At the six-month time point, we will contact participants to complete another short survey to determine the final set of eight-week goals throughout the remaining six months of the program. (See Table [1](#Tab1){ref-type="table"} for a complete goal list). This approach has been successfully implemented within several of our previous trials \[[@CR28], [@CR35], [@CR47]--[@CR50]\].Table 1Complete list of Balance behavior change goals for intervention armBALANCE BEHAVIOR CHANGE GOAL LISTMonths 1--6Months 7--12Universal goals assigned to all participantsMonths 1--2:Weigh yourself every dayMonths 3--4:Walk 7000 steps a dayMonths 5--6:Walk 10,000 steps a dayMonths 7--8:Weigh yourself every dayMonths 9--10:Walk 10,000 steps a dayMonths 11--12:Walk 10,000 steps a dayTailored goals assigned based on iOTA survey, 3 from this list, change every 2 months• No sugary drinks• No sweet snacks• No eating between 8 pm and 8 am^a^• No fast food• No fried food• Eat 5+ fruits and vegetables• No salty snacks• Eat at restaurants 1 time per week or less• Watch TV \< 2 h/day• Get brisk activity• Eat 5+ fruits and vegetables• Eat red meat 1 time per week or less• Get brisk activity• Watch TV \< 2 h/day• Do strength training• Eat whole grains in place of white• Eat a healthy breakfast• Sleep 7--8  h/night• No high-fat seasonings• Drink 4+ glasses water per day^a^Computer algorithm skips assigning this goal if participant has diabetes

### Self-monitoring and tailored feedback {#Sec12}

#### 2a. Self-monitoring through goal tracking {#FPar1}

Intervention participants will self-monitor adherence to their four behavior change goals each week during the 12-month intervention. To maximize engagement, we will provide opportunities for participants to self-monitor using either weekly interactive voice response (IVR) phone calls or text messages. Our IVR system will call participants and ask them to self-monitor the previous week's goals with their keypads or voices. Utilizing a library of hundreds of hours of professionally-recorded audio files, participants will hear a human voice, rather than a digitized voice, that requests tracking data and delivers tailored feedback based on their inputted responses. (See Additional file [2](#MOESM2){ref-type="media"} for a script of a sample IVR call). If participants do not respond to the initial call prompt, the system will send a text message 15 min later asking the goal questions. (Sample English and Spanish goal tracking text messages are depicted in Fig. [2](#Fig2){ref-type="fig"}). We have created an extensive retry protocol that continues to contact participants using both delivery channels. After our intervention delivery platform system receives a response from the participant, the system will immediately provide automated tailored feedback. Feedback messages will describe trends in progress, reinforce successes, offer motivational strategies, and short skills training tips (e.g., "Pack a healthy snack for the end of the day, when you may be tempted by fast food!"). This system has been tested previously in trials with great success in adherence to self-monitoring \[[@CR28], [@CR47]--[@CR50]\].Fig. 2Sample Balance goal tracking text messages (English and Spanish)

#### 2b. Self-monitoring through daily self-weighing {#FPar2}

In addition to self-monitoring behavioral goals via IVR or text, intervention participants will be asked to weigh themselves daily on a cellular-connected scale that will be shipped to participants immediately following enrollment. The scales transmit weight data directly through the cellular network; they do not require a computer, Internet, Bluetooth or wifi connection. Our intervention delivery platform will automatically receive all weight data, which will then be used to calculate average weekly weight changes for each participant. These weight data are used to trigger the responsive coaching interactions provided by Piedmont Health registered dietitians. (See Table [2](#Tab2){ref-type="table"}). If participants do not weigh on the scale at least once weekly, they will receive weekly automated text messages reminding them to weigh (e.g., "Looks like you didn't weigh yourself this week...").Table 2Balance weight zones and coaching modalityWeekly Weight ZoneAverage Weekly Weight Change, Compared to Baseline WeightCoaching ModeResponse to Weight ChangeGREEN\< 0 to 1.5 kgNoneAutomated text messages onlyYELLOW1.6 to 2.9 kgCoaching via text message onlyCustomized text messages from Balance dietitianRED≥ 3.0 kgCoaching via phone call and/or text messageBalance dietitian provides counseling via phone and/or text

### Responsive coaching {#Sec13}

Using the weight data described above, each week, our system will automatically categorize participants into one of three intervention zones - green, yellow or red - depending on their average weight change (calculated as an average weekly weight change minus average baseline weight). The specified weight zone determines the frequency, intensity, and mode of counseling (See Table [2](#Tab2){ref-type="table"}).

Green zone automated  messages(\<0--1.5 kg change from baseline) {#Sec14}
----------------------------------------------------------------

Participants who are within their green zone range, i.e. maintaining their weight or having lost weight since their baseline weight, will continue to track their goals. They will receive no coaching from a Balance dietitian; rather, they will receive one automated tailored feedback text message each week congratulating them for staying within their target weight zone and providing positive reinforcement and tips to remain in the "green zone."

Yellow zone text counseling (+1.6--2.9 kg change from baseline) {#Sec15}
---------------------------------------------------------------

On a daily basis, our system will automatically alert a Piedmont Health registered dietitian when a participant is in the yellow zone and needs motivational interviewing (MI)-guided counseling via text. MI enhances self-efficacy, increases recognition of inconsistencies between actual and recommended behaviors and teaches dissonance reduction skills \[[@CR51]\]. The goal of yellow zone text counseling is to provide brief MI interactions via text to raise participant awareness about weight gain; enhance self-efficacy for behavior change; and/or to encourage problem-solving \[[@CR52]\]. Dietitians will be trained and provided ongoing supervision and will utilize a library of special yellow zone skills training materials to counsel participants. In addition, because text messaging functionality will be built into our coaching interface, dietitians can access participant data to tailor their counseling text messages and view participant responses in real-time. Dietitians will be also be encouraged to limit their yellow zone texting frequency to a two outbound/two inbound text message exchange with participants at each coaching interval, but to use clinical discretion when more messages are needed.

Red zone phone/text counseling (≥3.0 kg from baseline) {#Sec16}
------------------------------------------------------

When notified that a participant has entered the red zone, the dietitian will make a counseling call attempt and/or send a customized text message within 24 h. We will establish a maximum of 12 calls per participant over the one-year intervention for the dietitian to distribute using his/her clinical discretion. Each 15 to 20-min counseling call will be designed to assess and enhance motivation and efficacy for behavior change based on weight change and self-monitoring data, deliver in-depth behavioral skills training, and provide social support, utilizing MI principles \[[@CR51], [@CR53]\]. For participants who prefer texting only, a robust counseling interaction may also occur via text (See Fig. [3](#Fig3){ref-type="fig"} for a sample red zone texting interaction).Fig. 3Sample red zone texting interaction between Balance registered dietitian and participant

### Skills training {#Sec17}

Intervention participants will receive printed skills training materials for maintaining a healthy weight, a cookbook and a pedometer to track steps. They will also receive animated videos with voiceover on how to achieve the assigned goals via DVD and YouTube links, with limited screen text for those with literacy challenges.

Data analysis {#Sec18}
-------------

This individually-randomized, stratified, two-arm parallel group, longitudinal trial will be powered on an unpooled two-sided chi-square test of a difference in two independent proportions, since the primary outcome is ≤3% weight gain at 24-months post randomization. We assume a difference in proportions of 0.16 (0.78 and 0.62 with ≤3% weight gain at 24 months in intervention and control participants, respectively), which is a conservative estimate based on 18-month post-baseline outcome data from our preceding work \[[@CR28]\]. With an alpha level of 0.05, we estimate to have approximately 90% power to detect a difference in proportions of this magnitude or larger. This estimate is based on an anticipated enrollment of 442 participants, with a dropout of up to 15% of participants during the course of the study \[[@CR47]\], resulting in a final primary outcome analysis sample size of 376 (188 per arm).

The primary analysis will be based on intention-to-treat principles where we assume that all participants have followed their randomized assignment. Clinical encounter data abstracted from Piedmont's EHR will be the primary data source. As we have described, an outpatient visit within the last 14 days is an enrollment criterion, enabling us to capture consistently timed baseline data. However, follow-up is captured within the EHR at varying and unequal time points. As such, all statistical analyses will account for these features of the data. For all continuous outcomes, we will fit a linear mixed effects model with at least one random parameter to model the effect of time (i.e., slope) and a random intercept for person. We may also include non-linearities (e.g., splines) for time in both the random and fixed part of the models, based on data summaries, BIC, and likelihood ratio tests. Knot locations will be determined using a priori knowledge of changes in outcome over a 24-month period, as well as through graphical display of study data to estimate a smoothed function. To ensure more precise estimates through 24 months post-enrollment, we plan to abstract EHR data at least an additional 3 months (i.e., 27 months post-enrollment) on all available subjects.

The statistical model will be adjusted for Piedmont Health community health center as a fixed term in the model to account for the stratified randomization design. Given randomization, no other variables will be adjusted in the primary mixed models. Assuming a linear trajectory, the model for continuous outcomes is parameterized as:
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where *Y*~*ij*~ is the outcome for person *i* at time *j*, *trt*~*i*~ is the intervention indicator for person *i*, *T*~*ij*~ is the continuous time (in months, with baseline as 0) for person *i* at time *j*, and *CHC*~*i*~ is the indicator of community health center for person *i*. In practice, this statistical model may be extended to allow for nonlinearities, as mentioned above.

For the primary outcome of weight gain prevention, we will compare the percentage ≤ 3% weight gain in each arm at 24 months using individual empirical best linear unbiased predictors (EBLUPs) from the mixed model. We will only use individual EBLUPs from participants with at least one EHR weight documented between 21 and 27-months post-baseline. We will compare the percentage ≤ 3% weight gain in intervention and control arms using a log-binomial model (or modified Poisson model \[[@CR54]\] if convergence of the model is not achieved) on the EBLUP output. The exponentiated parameter estimate for intervention arm will be interpreted as the risk ratio of greater than or equal to 3% weight loss in the intervention vs. the control arm. We will also compute the risk difference estimate using a linear risk model. For all other binary outcomes, we will use a generalized linear mixed model (GLMM) with a binomial distribution and log link with similar parametrization as described above.

We will assess the intervention's cost-effectiveness from the provider perspective. First, using an Activity Based Costing (ABC) approach \[[@CR55]\], we will identify the key activities that drive the overall costs and assign all labor, materials and supplies, and contracted services costs to their respective activities using intervention tracking forms that we have successfully applied in prior studies \[[@CR56]--[@CR59]\]. All costs will be valued at market rates. We will also identify which costs are sunk costs (e.g., software development) and which are incremental costs as only the latter will be used in cost effectiveness analysis. This will allow for quantifying incremental per capita costs. We will then apply these costs to per capita differences in weight outcomes across arms to quantify the incremental cost per kg of weight lost (or not gained) relative to control participants. Using these estimates, we will then convert results to incremental costs per quality-adjusted life year gained (QALY) following the approach presented in Finkelstein and Verghese \[[@CR60]\].

Discussion {#Sec19}
==========

The detrimental health effects of obesity are well-documented \[[@CR61]--[@CR65]\]. As obesity and its comorbidities continue to plague our patients and health systems, there is an increasing need to provide comprehensive obesity treatment within primary care with maximal reach to patients, particularly those who reside in remote areas. Digital technologies can facilitate the reach of efficacious treatments to medically vulnerable patients \[[@CR66]--[@CR68]\], those in dire need of effective weight management programs, but with the least access to these interventions \[[@CR10], [@CR11], [@CR69]--[@CR71]\]. Comprehensive obesity treatment solutions that comprise both weight loss and weight gain prevention interventions are particularly needed, especially by those in medically vulnerable circumstances. Weight gain prevention is clearly recommended in obesity treatment guidelines \[[@CR23]\], but not available or widely tested in the empirical literature. Given that up to half of the population of individuals with obesity are not attempting weight loss \[[@CR13]--[@CR15]\], weight gain prevention strategies are necessary to stem the near certainty of unhealthful weight gain, increasing the risk for morbidity and mortality.

Indeed, weight gain poses a near-inevitable threat across the lifespan among those who are not attempting weight loss. In the Coronary Artery Risk Development in Young Adults trial (CARDIA), a large national longitudinal study of 18 to 30-year-olds, only 10% of individuals could avoid weight gain over 15 years \[[@CR25]\]. Women are at particularly high-risk for weight gain, adding as much as 10% of their initial body weight in middle age \[[@CR25]\]. Many in medically vulnerable populations enter early adulthood having overweight or obesity and then gain weight more rapidly, and at a greater magnitude, than their lower risk counterparts \[[@CR72]--[@CR76]\]. Black women gain up to 1 kg/year, versus about 0.50--0.67 kg/year among White women \[[@CR72]--[@CR75], [@CR77]\]. First-generation Hispanic adults gain about 0.40 kg/year, which rises to 0.85 kg/year by the second generation \[[@CR78]\].

With weight gain a reality for so many medically vulnerable individuals, Balance is designed to be integrated within primary care, to provide a low-cost treatment option to as many adult patients as possible, in order to offer a remotely-delivered weight gain prevention strategy and healthy living content via a digital mode. To our knowledge, Balance is one of the first trials of a weight gain prevention intervention conducted within primary care. It is also one of few obesity trials to use a pragmatic approach to deliver and evaluate a digital intervention. In partnership with Piedmont Health, we will enhance our previous work to create a robust pragmatic approach to integrate a weight gain prevention treatment program into a network of community health centers that serve low-income, uninsured and underinsured patients, a large proportion who are monolingual Spanish-speakers.

The implementation of a pragmatic randomized controlled trial, such as Balance, creates an opportunity to assess the intervention's potential generalizability to other populations and settings. In addition, we hope the trial results will demonstrate the costs and practical implications of delivering weight gain prevention treatment options for an often overburdened healthcare system. Interventions designed a priori to be integrated within practical contexts and tested using pragmatic methods may offer the best potential to improve the health and lives of those tens of millions of patients with obesity and its associated health consequences.

Additional files
================

 {#Sec20}

Additional file 1:SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) diagrams. This diagram shows the content of the Balance clinical trial protocol and the flow for the recruitment, screening, allocation and follow-up of all enrolled participants. (PDF 45 kb) Additional file 2:Script of a sample IVR call. This diagram depicts a script of a sample interactive voice response call used by participants to track weekly behavior changes goals via phone. (DOCX 45 kb)
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